Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 5/20 | 0.57 |
| ▸ | MMP9 | P14780 | 3/20 | 0.57 |
| ▸ | PLAU | P00749 | 6/20 | 0.47 |
| ▸ | HPN | P05981 | 6/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 3/20 | 0.42 |
| ▸ | MMP1 | P03956 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5470145 | 1.00 | MMP2 (0.57) | MMP2MMP9PLAUHPNTDP1 | |
| SCHEMBL28509074 | 0.87 | MMP2 (0.60) | MMP2MMP9PLAUHPNTDP1 | |
| SCHEMBL10585071 | 0.86 | MMP9 (0.76) | MMP2MMP9PLAUHPNTDP1 | |
| SCHEMBL8001084 | 0.86 | MMP9 (0.76) | MMP2MMP9PLAUHPNTDP1 | |
| SCHEMBL457772 | 0.86 | MMP9 (0.76) | MMP2MMP9PLAUHPNTDP1 | |
| SCHEMBL6893970 | 0.86 | MMP2 (0.61) | MMP2MMP9PLAUHPNTDP1 | |
| Formaldehyde SCHEMBL28396754 | 0.85 | MMP2 (0.57) | MMP2MMP9PLAUHPNTDP1 | |
| SCHEMBL8322406 | 0.85 | MMP9 (0.71) | MMP2MMP9PLAUHPNTDP1 | |
| SCHEMBL200245 | 0.85 | MMP2 (0.57) | MMP2MMP9PLAUHPNTDP1 | |
| SCHEMBL200247 | 0.85 | MMP2 (0.57) | MMP2MMP9PLAUHPNTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0158981-B1 | NEW PROTEASE AND PROCESS FOR PRODUCTION AND USE THEREOF | SUNTORY LIMITED (JP) | 1991-07-10 | — | — | EP | claimed |
| EP-0230670-B1 | NOVEL HOST E. COLI AND USE THEREOF | SUNTORY LIMITED (JP) | 1991-07-03 | — | — | EP | claimed |
| US-20070269832-A1 | Novel affinity labels | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | 2007-11-22 | — | — | US | disclosed |
| US-20060148023-A1 | Affinity labeling of serine proteases for simultaneous detection of multiple serine protease activity levels | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | 2006-07-06 | — | — | US | disclosed |
| US-20050136492-A1 | Affinity labeling of enzymes for detection of enzyme activity level in living cells | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | 2005-06-23 | — | — | US | disclosed |
| WO-2003104394-A2 | NUCLEIC ACID MOLECULES ENCODING A TRANSMEMBRANE SERINE PROTEASE 12, THE ENCODED POLYPEPTIDES AND METHODS BASED THEREON | DENDREON SAN DIEGO LLC (US) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003059877-A2 | NOVEL AFFINITY LABELS | IMMUNOCHEMISTRY TECHNOLOGIES, LLC (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060466-A2 | AFFINITY LABELING OF SERINE PROTEASES FOR SIMULTANEOUS DETECTION OF MULTIPLE SERINE PROTEASE ACTIVITY LEVELS | IMMUNOCHEMISTRY TECHNOLOGIES, LLC (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003058194-A2 | AFFINITY LABELING OF ENZYMES FOR DETECTION OF ENZYME ACTIVITY LEVEL IN LIVING CELLS | IMMUNOCHEMISTRY TECHNOLOGIES, LLC (US) | 2003-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070269832-A1 | Novel affinity labels | ANPEP, SLC7A1, DNPEP | MMP2 50/4885MMP9 421/4885PLAU 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.